1. Home
  2. AMWL vs ELDN Comparison

AMWL vs ELDN Comparison

Compare AMWL & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$4.62

Market Cap

111.4M

Sector

Technology

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$2.21

Market Cap

123.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
ELDN
Founded
2006
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.4M
123.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
AMWL
ELDN
Price
$4.62
$2.21
Analyst Decision
Hold
Strong Buy
Analyst Count
7
2
Target Price
$7.58
$8.50
AVG Volume (30 Days)
88.7K
885.6K
Earning Date
02-11-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$265,023,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.33
N/A
52 Week Low
$3.71
$1.35
52 Week High
$12.95
$4.97

Technical Indicators

Market Signals
Indicator
AMWL
ELDN
Relative Strength Index (RSI) 44.97 73.04
Support Level $4.64 $1.70
Resistance Level $5.29 $1.76
Average True Range (ATR) 0.31 0.12
MACD -0.05 0.08
Stochastic Oscillator 5.00 93.83

Price Performance

Historical Comparison
AMWL
ELDN

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: